News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
875,853 Results
Type
Article (88363)
Company Profile (733)
Press Release (786728)
Multimedia
Podcasts (219)
Webinars (34)
Section
Business (233401)
Career Advice (4155)
Deals (39924)
Drug Delivery (166)
Drug Development (91534)
Employer Resources (207)
FDA (18479)
Job Trends (17459)
News (398294)
Policy (39997)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3037)
Academic (1)
Accelerated approval (46)
Adcomms (37)
Allergies (174)
Alliances (56985)
ALS (209)
Alzheimer's disease (1894)
Antibody-drug conjugate (ADC) (428)
Approvals (18726)
Artificial intelligence (713)
Autoimmune disease (252)
Automation (54)
Bankruptcy (407)
Best Places to Work (12631)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (453)
Bladder cancer (186)
Brain cancer (74)
Breast cancer (734)
Cancer (5739)
Cardiovascular disease (507)
Career advice (3584)
Career pathing (47)
CAR-T (334)
CDC (72)
Celiac Disease (2)
Cell therapy (905)
Cervical cancer (45)
Clinical research (77906)
Collaboration (2138)
Company closure (6)
Compensation (1336)
Complete response letters (95)
COVID-19 (3014)
CRISPR (111)
C-suite (1087)
Cystic fibrosis (159)
Data (7360)
Decentralized trials (3)
Denatured (82)
Depression (177)
Dermatology (67)
Diabetes (586)
Diagnostics (7415)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (348)
Drug pricing (232)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (101296)
Editorial (71)
Employer branding (25)
Employer resources (174)
Events (136566)
Executive appointments (1120)
FDA (22095)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1755)
Gene editing (238)
Generative AI (71)
Gene therapy (750)
GLP-1 (1198)
Government (5509)
Grass and pollen (8)
Guidances (403)
Healthcare (21029)
HIV (80)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (325)
Immuno-oncology (96)
Indications (164)
Infectious disease (3364)
Inflammatory bowel disease (224)
Inflation Reduction Act (17)
Influenza (138)
Intellectual property (286)
Interviews (817)
IPO (17972)
IRA (60)
Job creations (5205)
Job search strategy (2869)
JPM (72)
Kidney cancer (20)
Labor market (106)
Layoffs (669)
Leadership (46)
Legal (10166)
Liver cancer (106)
Longevity (29)
Lung cancer (765)
Lymphoma (421)
Machine learning (56)
Management (66)
Manufacturing (1026)
MASH (196)
Medical device (15138)
Medtech (15224)
Mergers & acquisitions (23127)
Metabolic disorders (1585)
mRNA (218)
Multiple sclerosis (186)
NASH (24)
Neurodegenerative disease (435)
Neuropsychiatric disorders (116)
Neuroscience (3439)
Neurotech (1)
NextGen: Class of 2026 (7693)
Non-profit (5129)
Now hiring (75)
Obesity (768)
Opinion (359)
Ovarian cancer (202)
Pain (253)
Pancreatic cancer (275)
Parkinson's disease (368)
Partnered (38)
Patents (590)
Patient recruitment (643)
Peanut (65)
People (67457)
Pharmaceutical (128)
Pharmacy benefit managers (36)
Phase 1 (24062)
Phase 2 (33839)
Phase 3 (25456)
Pipeline (7566)
Policy (372)
Postmarket research (3555)
Preclinical (10791)
Press Release (72)
Prostate cancer (293)
Psychedelics (61)
Radiopharmaceuticals (334)
Rare diseases (1118)
Real estate (7448)
Recruiting (81)
Regulatory (29722)
Reports (74)
Research institute (2746)
Resumes & cover letters (653)
Rett syndrome (34)
RNA editing (23)
RSV (94)
Schizophrenia (179)
Series A (294)
Series B (219)
Service/supplier (27)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (4350)
State (2)
Stomach cancer (21)
Supply chain (137)
Tariffs (102)
The Weekly (134)
Vaccines (1229)
Venture capital (111)
Weight loss (521)
Women's health (120)
Worklife (23)
Date
Today (145)
Last 7 days (561)
Last 30 days (2694)
Last 365 days (32194)
2026 (9320)
2025 (32408)
2024 (37808)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (372)
Arkansas (16)
Asia (51907)
Australia (9121)
California (12896)
Canada (3648)
China (1354)
Colorado (552)
Connecticut (560)
Delaware (387)
Europe (119462)
Florida (1934)
Georgia (422)
Hawaii (4)
Idaho (69)
Illinois (1087)
India (91)
Indiana (596)
Iowa (24)
Japan (517)
Kansas (138)
Kentucky (51)
Louisiana (44)
Maine (80)
Maryland (1583)
Massachusetts (9442)
Michigan (382)
Minnesota (730)
Mississippi (7)
Missouri (156)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (89)
New Jersey (3463)
New Mexico (33)
New York (3422)
North Carolina (1761)
North Dakota (10)
Northern California (6298)
Ohio (390)
Oklahoma (26)
Oregon (52)
Pennsylvania (2579)
Puerto Rico (29)
Rhode Island (53)
South America (1667)
South Carolina (83)
South Dakota (2)
Southern California (5044)
Tennessee (204)
Texas (2059)
United States (46328)
Utah (388)
Vermont (1)
Virginia (318)
Washington D.C. (88)
Washington State (1060)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
875,853 Results for "cn bio innovations formerly known as zyomyx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
28bio’s Endurance Study Meets Primary Endpoint, Showing CNS-3D Brain Organoids Predict Clinical Seizure Liability
March 23, 2026
·
2 min read
Press Releases
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer’s Therapies with Broad CNS Delivery Applications
March 26, 2026
·
2 min read
Press Releases
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
February 12, 2026
·
6 min read
Mergers & acquisitions
Lilly wants to bridge cancer care gap with $300M ADC biotech buy
Eli Lilly is putting its obesity windfall to work again, striking a new deal to acquire CrossBridge Bio, a small Texas biotech known for its cancer tech.
April 14, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
March 11, 2026
·
1 min read
Press Releases
D3 Bio to Showcase Its Innovative KRAS Pipeline at AACR 2026, Including an Oral Presentation at Clinical Plenary Session
March 20, 2026
·
4 min read
Press Releases
Formation Bio Licenses Phase 1-Ready CNS Penetrant TYK2 Inhibitor from Lynk Pharmaceuticals
December 11, 2025
·
4 min read
Press Releases
Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio’s Metagenomic Sequencing Test for Improving CNS Diagnosis
November 17, 2025
·
3 min read
Press Releases
Korsana Biosciences to Present at the Stifel 2026 Virtual CNS Forum
March 12, 2026
·
1 min read
Press Releases
Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million
March 27, 2026
·
4 min read
1 of 87,586
Next
